Switglim MP 1mg/500mg/7.5mg Tablet
Marketer
Akumentis Healthcare Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (7.5mg)
Overview Switglim MP 1mg/500mg/7.5mg Tablet
GlucoTrim Rx 1mg/500mg/7.5mg tablets combine medications to manage blood glucose. This therapy, used alongside diet and exercise, improves glycemic control in adult type 2 diabetics. It enhances insulin effectiveness, reducing blood sugar. Follow your physician's prescribed dosage and schedule for GlucoTrim Rx 1mg/500mg/7.5mg tablets; take with food to prevent digestive discomfort. If a dose is missed, take it promptly unless the next dose is imminent; then, omit the missed dose and resume your regular schedule. Never double the dose; overdose can cause hypoglycemia. Concurrent use with other diabetes medications, alcohol, or skipped meals may increase hypoglycemia risk; regular blood sugar monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Disclose kidney, liver, or heart conditions to your doctor before starting treatment. Pregnant or lactating individuals must consult their physician. Kidney function tests will be conducted prior to treatment initiation. Limit alcohol consumption as it may exacerbate side effects.
Uses of Switglim MP 1mg/500mg/7.5mg Tablet
Managing type 2 diabetes
Major Benefits of Switglim MP 1mg/500mg/7.5mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Switglim MP 1mg/500mg/7.5mg tablets should be administered with a meal.
Common Side effects of Switglim MP 1mg/500mg/7.5mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Switglim MP 1mg/500mg/7.5mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Switglim MP 1mg/500mg/7.5mg tablets should be administered with a meal.
How Switglim MP 1mg/500mg/7.5mg Tablet works:
Switglim MP tablets (1mg/500mg/7.5mg) combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. These medications act via separate pathways to optimize blood glucose management when monotherapy or dual drug regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar levels. Metformin, a biguanide, reduces hepatic glucose production, slows intestinal glucose uptake, and enhances insulin responsiveness. Pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Switglim MP 1mg/500mg/7.5mg Tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Switglim MP 1mg/500mg/7.5mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a fetus. A physician will assess the potential benefits against any risks before prescribing this medication. Seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
The use of Switglim MP 1mg/500mg/7.5mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Switglim MP 1mg/500mg/7.5mg tablets cautiously, potentially requiring dosage modification. Consult your physician for guidance. The medication is contraindicated in patients with severe kidney disease. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Switglim MP 1mg/500mg/7.5mg tablets cautiously, potentially requiring a modified dosage. Medical advice is recommended. Switglim MP 1mg/500mg/7.5mg tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Switglim MP 1mg/500mg/7.5mg Tablet :
Should you forget a dose of Switglim MP 1mg/500mg/7.5mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Switglim MP 1mg/500mg/7.5mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently